Expansion of stem and progenitor cells from UCB cultivated in the presence or absence of estradiol

<p><b>Copyright information:</b></p><p>Taken from "Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer"</p><p>Cancer Cell International 2007;7():11-11.</p><p>Published online 8 Jun 2007</p><p>PMCID:PMC1904434.</p><p></p> (A) Fold increment in CD133+/CD34+, CD133-/CD34+, and CD133+/CD34- cell number after 7, 14, and 21 days in culture. (B) Flow cytometry analysis showing percentage of mononucleated cells expressing CD133 prior to and after culturing for 7 days. Positive and isotype controls are provided in supplemental figure S2. (C) Functional clonogenic assay based on the frequency of colony forming units (CFU). Data correspond to fold expansion of myeloid and endothelial progenitors at culture day 7. GF = basal medium supplemented with growth factors only (SCF, IL3, IL6, and Flt3-ligand); E2 = medium supplemented with growth factors plus 10 nM estradiol. Statistical significance for GF vs. E2 comparisons: * < 0.01, **< 0.001